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Leukolrienr A4 may be metabolized to 5(S),6(R)- and S(S).6(S)-dihydroxy-7,9-r~urIs-1 I, 14-cis-cicosatelracnoicacids by enzymalic or non-enzymatic 
hydrolysis. Incubation of human platelet suspensions with these dihydroxy acids led to Lhe formation of lipoxin A, and 6(S)-ligoxin A, via 
lipoxyyenation at C-l 5. Furthermore, human platelets converted the IWO S(R),B(S)- and 5(R),6(R)-dihydroxy-7,9-rran~-l1,14-cis-eicosate\raenoic 
acids to tetraene-containing trihydroxyeicosatetraenoic acids. In contrast, leukotricncs C,, D4 and E, were not transfcrmed 10 cysleinyl-lipoxins. 
Time-course studies of Ieukolriene A., metabolism in human platelet suspensions indicated lipoxin formation via two pathways: (i) direct conversion 
of leukotriene A,, leading to formation of the lipoxin intermediate 15.hydroxy-leukotrirllc A,; and (ii) IS-lipoxygenation of the 5(S),6(R)- and 
S(S),ci(S)-dihydroxyeicosatetraenoic acids. The results demonstrate that lipoxygenation al C-15 of S,6-dihydroxy-7,9,I1.14-eicosatetracnoic acids
may be an alternative novel pathway for platelet-dependent lipoxin formation. 
Lipoxin; 5.6.Dihydroxyeicosatetraenoic acid; 12.Lipoxygenase; Human platelet 
1. INTRODUCTION 
Non-enzymatic hydrolysis of the unstable epoxide 
lzukotriene (LT) Ail leads to formation of the two C-12 
epimcrs of G-rrurls-LTB,. In addition, two C-6 epimers 
5(S),6(R)- and S(S),6(S)-dihydroxy-7,9-fr~~z~,l1,14-cis- 
eicosatetraenoic a id (5,6-diHETE) are formed [I]. En- 
zymatic transformation of LTA4 to 5(S),6(R)-diHETE 
mediated by a liver cytosolic epoxide hydrolase has 
been demonstrated 121. Furthermore, 5(S),6(R)-di- 
HETE may also be formed from 5-HETE via a 6(R)- 
oxygenase activity of the S-lipoxygenase in porcine Ieu- 
kocytes [3]. The biological activities of the S,6-diHETEs 
are not yet fully elucidated. However, contractile effects 
on both lung parenchyma [4] and ileum of the guinea 
pig have been reported. Interestingly, S(S),b(R)-di- 
HETE was shown to interact with the LTDl receptor 
in guinea pig lung membranes [5]. In addition, 5,6-di- 
METE stimulated protein kinase C in vitro [6]. 
The lipoxins are trihydroxylated arachidonic acid 
deratives, containing a conjugated tetraene. They are 
biologically active compounds, which induce e.g. bron- 
choconstriction, vasodilation, stimulation of protein ki- 
nase C and inhibition of NK cells [7]. In addition, 
lipoxin (LX) A4 has also been suggested to antagonize 
leukotriene-induced effect, which implies an anti-in- 
Corre~pondemce address: S. Tornhomre, Department of Physiological 
Chemistry, Karolinska Institutet, Box 60400, S-10401 Stockholm, 
Sweden. 
flamrnatory role oT this compound [g-lo]. Recently 
lipoxin-mediated mrldulation of human myeloid stem 
cell growth was demonstrated [ 111. 
Lipoxin synthesis may occur via different pathways. 
The isolation of lipoxins from leukocyte suspensions 
ncubated with 1 S(S)-hydro(pero)xyeicosatetraenoic 
acid (15-H(P)ETE) indicated the importance of the 5- 
and 15-lipoxygenases in lipoxin formation [ 12,131. In 
accordance, we reported lipoxin synthesis from en- 
dogenous substrate in mixed incubations of human 
granulocytes possessing S-lipoxygenase activity and res- 
piratory tissue, which is rich in I S-lipoxygenase activity 
[ 141. Furthermore, human platelets efficiently metabol- 
ized exogenous or granulocyte-derived LTA,(5,6- 
epoxy-7,9-rrflns-11,14-cis-eicosatetraenoic acid) to 
lipoxins [IS-I 71. This synthesis proceeded via 12-lipoxy- 
genase-dependent hydroxylation at carbon 15 leading 
to formation of the unstable intermediate IS-OH-LTA4 
[ 171. The present study demonstrates that human plate- 
lets possess the capacity to convert 5,6-diHETEs to 
lipoxins, including the biologically active LXAJ, 
2. MATERIALS AND METHODS 
2.1. Murcriuls 
The four epimers of 5,6-dihydroxy-7,9-rrrrns-I 1,14-cis-eicosate- 
traenoic acid (S(S),G(R)-diHETE; S(S),6(S)-diHETE; 5(R),6(R)-di- 
HETE: S(R),G(S)-diHETE) were synthesized as reported [IS], Syn- 
thetic LTAJ methyl ester was purchased from Salford Ultrafine Chem- 
icals (Manchesier, UK) and was saponified as rcporled [7]. Lipoxins 
A, and BJ were purchased from Cayman Chemical Co. (Ann Arbor, 
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Fig. 1, Reversed-phase HPLC chromatograrns of lipoxins formed by human platelet suspensions after incubation with (A) S(S).6(R)-diHETE, (6) 
S(S),6(S)-diHETE. (C) S(R),B(R)-diHE?‘E and (D) S(R),6(S)-diHETE. Incubations were performed for 30 min at 37OC in the presence of ionophorc 
A231 87 (I PM). Retention times of synthetic standards are indicated by arrows. 
Ml, USA). The all trum isomers of LXAJ, LXBd and 6(S)-LXA, were 
kindly provided by Dr, KC. Nicolaou (Univ. of Penn., PA, USA), 
while 7-cis-1 I-WUWLXA., was a Rift from Dr. C.N, Serhan (Harvard 
Medical School, Boston, MA, USA). Leukotricnes Cd, Do and E, were 
synthesized as described [19,20]. lonophore A23187 was obtained 
from Calbiochcm Bchring (La Jolla, CA, USA), fatty acid-free human 
serum albumin and soybean IipoxyJenasc from Sigma (St. Louis, MO, 
USA). 
Leukotriencs C,, Dd, E, (2 prg) W&6(R)-diHETE or S(S),b(S)-di- 
HETE (2 nmol) were incubated svith soybean lipoxygcnase (50.000 
lJ/mg, 20 pg) as described earlier [21,?2]. Incubations were performed 
in phosphate-buffered saline (PBS; Dulbecco’s formula without Ca2’/ 
&I$*; pH 7.4). The Ieukotrienes and the $6.diHETEs were incubated 
for 60 min at room temperature or for 30 min at 37OC, respectively. 
The reaction was monitored by UV spectroscopy with scanning he- 
tweet? 250 and 350 nm (HP 8450A, Hewlett Packard, CA, USA) and 
stopped by addition of 1 vol. of methanol. Thereafter NaBH, was 
added to reduce the hydroperoaidcs. After I5 min, HCI (1 M) was 
added to obtain pH 6, prior to addition of I vol. of PBS. The samples 
were applied on preconditioned Baker-C,, disposable columns (500 
mg). extracted with 3 nil of waler, 2 ml of 25% methanol and were 
finally eluted with 2 ml of mcthxnol. 
2.3. Prepurattm and itwubatton ofphtekr susperrsiom 
Peripheral human blood from healthy donors was collected using 
EDTA (77 mM 7.5% v/v) as anticoagulant. The platclct-rich plasma 
was removed after centrifugation at 200 x g for 15 min and the plate- 
lets were washed lwicc with Tris-buffered (pH 7.4) saline containing 
I .5 mM sodium EDTA. Finally the cells were resuspended in PBS to 
a concentration of approximately 450 x IOb plnteletslml. The platelet 
suspensions were equilibrated for 5 min at 37OC prior to incubation 
with various concentrations of the S,6-diHETE isomers, I PM LXA4 
or 10 PM LTAl for various times or with IOpM LTC,, D, or Ea for 
30 min. All incubations were performed in the presence of ionophore 
A23 I87 (I gM), Human serum albumin (0.3 mS/ml) was always added 
heftire incubation with LTA,. Reactions were terminated by addition 
of 5 vols. of ethanol. 
2.4. Product pur~~cuttoorr and itictttiJiCCltio~~ 
After centrifugation and evaporation of the samples, the remaining 
material was dissolved in 250 ~1 of 5050 mcthanol/watcr (v/v). Re- 
versed-phase HPLC was performed, using an Ultrasphere-ODS col- 
umn 250 x 4.6 mm or 150 x 4.6 mm (Beckman Ban Ramon, c‘A, 
USAj, eluted with mcthanoUwater/aeetic acid (50:4f.!~C.O1 v/v) or ace- 
tonitrile/methanol/water/acetic ac d(23: 15:61 :O.S. v/v. apparenl pH 
5.6), respectively, at a ilow rate of I mUmin. A computerized diode 
array spectrophotometer (HP 8451 A, CA. USA) or a variable wavc- 
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FiB. 2. Dose-response curves of p]atelet.depcndent lipoxin formation from exogenous 5,6-diHETEs. Human platelet suspensions were incubated 
for 30 rain at 37°C in the pres¢nce of ionophore A23187 (1/.tM), The amounts of the products are successiv¢ly added together and prcs¢nted as 
an area graph (peaks [, II and 1II, cf. Fig. i). 
length UV detector (Kratos Spectroflow 783, Ramsey, N J, USA) 
connected to an inteBrator (Spectra Physic 4270, San JosS, CA, USA) 
was used/'or UV-detcction at 302 nm and quantitation ofthe products. 
The c8mpounc:s were identified by co-chromatography with synthetic 
or biosynthetic standards and by on-line UV spectroscopy. 
3. RESULTS AND DISCUSSION 
Human platelet suspensions were incubated with ei- 
ther of the four 5,6-diHETE epimers. Each epimer was 
converted to three products, absorbing at 302 nm and 
eluting as distinct peaks on reversed.phase HPLC (Fig. 
1). Ad judged by UV spectroscopy, allcompounds con- 
tained conjugated tetraenes, possessing maximal ab- 
sorbance at 302 nm and shoulders at 288 and 316 rim. 
The lipoxin formation was markedly stimulated by cal- 
cium ionophor¢ A23187. Thus, incubation of platelets 
with 5(S),6(R)-diHETE (6/~M) led to the formation of 
56 and 744 pmol LXAJml, in the absence and presence 
of A23187 (1/~M), respectively. This is in accordance 
with the effect of A23187 on the conversion of LTA4 to 
lipoxins [23]. The conversion of 5,6-diHETEs to lipox- 
ins increased in a substrate concentration-dependent 
manner (0-40 ~tM) (Fig. 2). 
The 5(S),6(R)-diHETE isomer was converted to one 
major and two minor lipoxins (Fig. 1). The major com- 
pound (peak Ill:A) co-elutcd with synthetic LXA4. One 
of the two minor peaks (peak IhA) co-elated with I l- 
tran~'-LXA4, while the second minor compound (peak 
I:A) eluted at a shorter etention time. This compound 
did not co-elute with synthetic 7.cis-11-trans-LXA4 [24]. 
Incubations with 5(S),6(S)-diHETE led to the, forma- 
tion of three compounds in approximately similar 
amounts. Two of these lipoxin isomers co-chromatogra- 
phed with 6(S)-LXA4 (peak III:i3) and 6(S)-11-trans. 
LXA4 (peak II:B), respectively, while the third product 
displayed a shorter etention time (peak I:B). Platelets 
incubated with 5(R),6(R)-diHETE or 5(R),6(S)-di- 
HETE formed one major and two minor more polar 
lipoxin products, from the respective substrate. The 
major lipoxins eluted at longer retention times than 
LXA~ (peaks III:C and Ill:D; Fig. 1). In analogy with 
the conversion of 5(S),6(R)- and 5(S),6(S)-diHETE, the 
formation of 5(R)-LXA4, 5(R),f(S)-LXA~ and the l l- 
trans isomers of these compounds can be speculated. 
Thus, peaks II:C and III:C would most probably be 
5(R)- 11-trans-LXA4 and 5(R)-LXA4, whereas II:D and 
III:D would be 5(R),6(S)-I 1-trans-LXA4 and 5(R),6(S)- 
LXA4, respectively. The various 1 l-trans-lipoxin-iso- 
mers obtained from the four 5,6-diHETEs were proba- 
bly formed by spontaneus trans.isomerisation f the 
corresponding LXA4 isomer. Thus, isomerisation of 
5,6-diHETEs to 1 l-trans-5,6-diHETEs would lead to 
formation of" substrates, lacking the iatramoleealar 1 °4- 
cis-pentadiene structure which is a prerequisite for sub- 
strates participating in lipoxygenase catalyzed reactions 
[25]. Furthermore, a significant rans-isomerisation t  
11-trans-LXA~ was observed in a buffer solution of 
LXA, kept at room temperature for 48 h (result not 
shown). 
The structures of peaks I:A-D (Fig. 1) are unknown. 
Since the product formed from 5(S),6(R).diHETE did 
not co-elate with 7-cis, l l-trans-LXA4, a 7-c/s,l 1-trans 
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Fig. 3. Time-course of platelet-dependent conversion of LTA, to 
lipoxins. Human platelet suspensions were incubated with LTA, (10 
PM) at 37°C in the presence of human serum iilhumin (0.3 mg/ml) and 
ionophore A23187 (1 ,uM). (A) LXAr and LXA4-isomers; and (A) 
all-rrans-LXB,-isomers. 
double-bound configuration of these compounds can 
probably be excluded. Incubations of 5(S),6(R)- and 
5(S),6(S)- with soybean lipoxygenase resulted in forma- 
tion of identical products as those obtained in platelet 
incubations (results not shown). These findings exclude 
the possibility that the unknown compounds eluting in 
peaks l:A-D are IS(R)-LXAJ isomers, since the soy 
bean lipoxygenase is specific for a 1 S(S)-hydroxylation 
[26]. Furthermore, the results indicate that the products 
are nor formed by a plateletdependent isomerase, In 
addition, the compounds formed by 1 S-lipoxygenase 
were not reduced by NaBH,, which excludes the possi- 
bility that they were 1 S-OOH-LXA4 isomers. Finally, w- 
metabolism of LXAJ and LXB, in human leukocytes 
has been reported [27]. To investigate whether w-metab- 
olism of lipoxins could be performed by platelets, plate- 
let suspensions were incubated with LXA+ Except 
rrrms-isomerisation f LXA4 to 1 I-trams-LXA, no me- 
tabolism to tetraene-containing compounds cou!ci be 
observed (results not shown). This is in accordance with 
the reported inability of human platelets to convert 
LTBa to w-metabolites [28]. 
Formation of cysteinyl lipoxins in human eosinophils 
after incubation with IS-METE and ionophore A23187 
has been reported [22]. It was therefore of interest o 
investigate the capacity of human platelets to trausftirm 
the cysteinyl-leukotrienes to the corresponding lipoxins. 
Platelet suspensions were incubated for 30 min with 
LTC,, D4 or EJ (10 ,uM) in the presence of calcium 
ionophore A23187 (1 PM). Detectable amounts of cys- 
teinyl lipoxins could not be observed in these experi- 
ments. Taken together the results indicate that platelet- 
dependent 1 S-hydroxylation is independent of the con- 
figuration of the hydroxyl groups at carbons 5 and 6. 
In contrast, the reaction is inhibited by the presence of 
zoo0 1 
Time (min) 
Fig. 4. Timc-coursc of the conversion ofexogenous S(S)&R)diHETE 
(10 PM) to lipoxins in human platelets. The incubations were pcr- 
formed at 37°C in the presence of A23 I87 (I PM). (m) LXA,; (a) 
1 I-firms-LXA,; (0) peak I (cf. Fig. I). 
the cysteinyl-containing substituents of leukotrienes C,, 
D,, or E4 at carbon 6. 
Addition of LTA., (1OpM) to human platelet suspen- 
sions induced rapid formation of LX&, 6(S)-LX&, 
6(9-l I-trurts-LXA4, 11 -trams-LXA, and all-trans-LXBd 
isomers during the first 5 min of incubations (Fig. 3). 
Thereafter the production of LXA, and the LX&-iso- 
mers continued although at a lower formation rate. In 
contrast, the all-truns-LXB,-isomers, which can only be 
formed from the tetraene poxide, ceased after 5 min. 
These results indicate that lipoxins are formed from 
LTAl via two different pathways in human platelets. 
First, a rapid conversion of LTAJ to the unstable 
lipoxin intermediate, I S-OH-LTAo occur, followed by 
a subsequent hydrolysis of this tetraene poxide to the 
various lipoxins [17]. Second, LTA, is hydrolyzed to the 
stable 5@),6(R)-diHETE and S(S),6(S)-cliHETE, which 
are subsequently ipoxygenated at C-15, leading to for- 
mation of LXA4 and 6(S)LXA4, respectively. In agree- 
ment, incubation of platelets with S(S),6(R)diNETE 
(10 ,uM) led to formation of LXA4 and 1 I-trans.LXA,, 
which increased with time (O-i 20 min; Fig. 4) Interest- 
ingly, the formation rates of LXAJsomers were ap- 
proximately the same after 30 min, whether LTA., or 
S(S),6(R)-diHETE were used as substrate. 
In summary, the present finding demonstrates that 
human platelets convert 5,6diHETE to lipoxins. In 
contrast, the platelets were unable to transform cys- 
teinyl-leukotrienes to the corresponding lipoxins. Fur- 
thermore, the results indicate that plateletdependent 
lipoxin formation from LTAJ proceeds both via lipoxy- 
genation of the unstable tetraene poxide and via initiai 
conversion of LTA., to 5,6-diHETE, and subsequent 
lipoxygenation at C-15. The latter route of formation 
81 
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may be of special importance in certain tissues, such as 
the liver and lung, with high epoxide hydrolase activity 
[251, leading to enzymatic formaton of 5(S),6(R)-di- 
HETE. 
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